Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Small-molecule alpha4 integrin antagonists generation disclosed by Biogen

May 31, 1996

Potential hypoxic marker synthesized by Evanston Hospital

May 31, 1996

PKC pathway activation may have therapeutic significance in bone disease management

May 31, 1996

OC104-26 identified as multidrug resistance (MDR)-reversing agent

May 31, 1996

ISIS-7597, an antisense oligonucleotide, shows promise in battling multidrug resistance

May 31, 1996

A highly lipophilic delta7-PGAI analogue, TEI-9826, demonstrates antitumor activity

May 31, 1996

Ligand reveals RXR-selective retinoid

May 31, 1996

MF-13 revealed as a selective tumor apoptosis-inducing agent

May 31, 1996

NSC-652287D shows important antitumor activity

May 31, 1996

Ciba-Geigy describes CGP-59326, a powerful antitumor agent

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...